Pharmacy chains activity analysis

Pharmacy chains activity analysis

Russian pharmaceuticals retail chain segment evaluation, both on the level of the state and in particular regions. Pharmacy chains development forecast


Product sales and separate market development forecast, based on unique mathematical models

Business and marketing plan development

Development of detailed business-plans, required to evaluate the reasonability of project start

Search of partners for contract production in Russia

Potential partners search and evaluation, based on their technical opportunities, appropriate experience, and reputation

Monitoring of import substitution

assessment of the main trends of import substitution policies and localization processes in the pharmaceutical market in Russia, the key beneficiaries and companies at risk

Rating of Banks Performing Payment Transactions of Russian Import of Pharmaceutical Drugs (Q1 2015)

Friday, May 22, 2015

Nearly 70 banks perform payment transactions of the import of pharmaceutical drugs to Russia, with the top-5 banks performing 69.4% of all the transactions made in the first quarter of 2015. The absolute leader is Citybank, performing 38.4% of the transactions in monetary terms. It is followed by Deutsche Bank and Sberbank.

Sberbank is also the absolute leader in the number of importers they work with (39 companies in Q1 2015). Certain banks work only with one pharmaceutical company, for example, Crédit Agricole and First Czech-Russian Bank cooperate with Aventis Pharma and Prom. Medik. Rus., respectively. However, as of Q1 2015, Aventis Pharma works with two banks.

Top-15 banks performing payment transactions of Russian import of ready-made pharmaceutical drugs, in monetary terms (Q1 2015)